Acarbose and Hepatic function abnormal - a phase IV clinical study of FDA data

Summary:

Hepatic function abnormal is reported as a side effect among people who take Acarbose (acarbose), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lenvatinib, and have High blood pressure.

The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Acarbose. It is created by eHealthMe based on reports of 4,551 people who have side effects when taking Acarbose from the FDA, and is updated regularly.

What is Acarbose?

Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,470 drugs and 2,013 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.

On Jan, 17, 2026

4,551 people reported to have side effects when taking Acarbose.
Among them, 39 people (0.86%) have Hepatic function abnormal.

Could Acarbose cause Hepatic function abnormal?

Among these 39 people:

How long have people been on Acarbose when they have Hepatic function abnormal? *

What is the gender of people who have Hepatic function abnormal when taking Acarbose? *

female: 37.84 %
male: 62.16 %

What is the age of people who have Hepatic function abnormal when taking Acarbose? *

What are other drugs people take besides Acarbose? *

Lenvatinib: 5 people, 12.82%
Zetia: 4 people, 10.26%
Amlodipine: 4 people, 10.26%
Myfortic: 4 people, 10.26%
Metformin Hydrochloride: 4 people, 10.26%
Amaryl: 4 people, 10.26%
Calcium: 3 people, 7.69%
Promethazine: 3 people, 7.69%
Glimepiride: 3 people, 7.69%
Hydrochlorothiazide: 2 people, 5.13%

What are other side effects people have besides Hepatic function abnormal? *

Alanine Aminotransferase Increased: 9 people, 23.08%
Aspartate Aminotransferase Increased: 5 people, 12.82%
Blood Albumin Decreased: 4 people, 10.26%
Renal Impairment (severely reduced kidney function): 3 people, 7.69%
Haemoglobin Decreased: 3 people, 7.69%
Incision Site Pain: 3 people, 7.69%
Leukopenia (less number of white blood cells in blood): 3 people, 7.69%
Lymphocyte Count Decreased: 3 people, 7.69%
Blood Urea Increased: 3 people, 7.69%
Protein Urine Present: 3 people, 7.69%

What are the existing conditions these people have? *

Type 2 Diabetes: 13 people, 33.33%
High Blood Pressure: 13 people, 33.33%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 15.38%
Hepatocellular Carcinoma (liver cancer): 5 people, 12.82%
Infection: 4 people, 10.26%
Productive Cough: 4 people, 10.26%
Blood Glucose Increased: 4 people, 10.26%
Cough: 4 people, 10.26%
Sedation: 4 people, 10.26%
Urination - Excessive Volume: 4 people, 10.26%

* Approximation only. Some reports may have incomplete information.

Do you take Acarbose and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acarbose:

Acarbose (4,605 reports)

Browse all side effects of Acarbose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic function abnormal:

Hepatic function abnormal (1,470 drugs)

Browse all the conditions that are associated with Hepatic function abnormal:

Hepatic function abnormal (2,013 conditions)

Drugs similar to Acarbose and Hepatic function abnormal :

How the study uses the data?

The study uses data from the FDA. It is based on acarbose (the active ingredients of Acarbose) and Acarbose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.